SCHEMBL25836038

SCHEMBL25836038

CCCCCC(CCCCC)N1CC2(CN(C)C2)C1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.35
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21160999 0.98 FDPS (0.37) FDPSOPRM1
SCHEMBL21161001 0.98 FDPS (0.37) FDPSOPRM1
SCHEMBL25834503 0.98 FDPS (0.37) FDPSOPRM1
SCHEMBL21106970 0.84 GUSB (0.40) FDPS
SCHEMBL20892894 0.84 GUSB (0.40) FDPS
SCHEMBL18559492 0.82 OPRM1 (0.35) FDPSOPRM1
SCHEMBL18559563 0.82 OPRM1 (0.35) FDPSOPRM1
SCHEMBL24688132 0.79 FDPS (0.34) FDPSOPRM1
SCHEMBL25812980 0.79 FDPS (0.37) FDPSOPRM1
SCHEMBL21650580 0.78 FDPS (0.36) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR FDPS 3420/4885OPRM1 3117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.